Acorda Therapeutics (ACOR) Tops Q1 EPS by 1c
Get Alerts ACOR Hot Sheet
Price: $13.50 --0%
Revenue Growth %: +63.1%
Financial Fact:
Net sales: 128.51M
Today's EPS Names:
DSGN, ATRA, CRVS, More
Revenue Growth %: +63.1%
Financial Fact:
Net sales: 128.51M
Today's EPS Names:
DSGN, ATRA, CRVS, More
Join SI Premium – FREE
Acorda Therapeutics (NASDAQ: ACOR) reported Q1 EPS of $0.15, $0.01 better than the analyst estimate of $0.14. Revenue for the quarter came in at $99.85 million versus the consensus estimate of $100.2 million.
For earnings history and earnings-related data on Acorda Therapeutics (ACOR) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- FreightCar America (RAIL) Misses Q4 EPS by 6c, provides guidance
- Singular Genomics Systems, Inc. (OMIC) Reports In-Line Q4 EPS
- Lantern Pharma (LTRN) Tops Q4 EPS by 1c
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!